Depreciation of INTERCEPT PHARMACEUTICALS, INC. from 31 Dec 2010 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2010 to 31 Mar 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Depreciation for the quarter ending 31 Mar 2023 was $89,000, a 74% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Depreciation for 2022 was $592,000, a 79% decline from 2021.
  • INTERCEPT PHARMACEUTICALS, INC. annual Depreciation for 2021 was $2,814,000, a 4.4% decline from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Depreciation for 2020 was $2,943,000, a 20% decline from 2019.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $89,000 -$252,000 -74% 01 Jan 2023 31 Mar 2023 10-Q 27 Apr 2023 2023 Q1
Q1 2022 $341,000 -$529,000 -61% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023 2023 Q1
Q1 2021 $870,000 +$106,000 +14% 01 Jan 2021 31 Mar 2021 10-Q 06 May 2022 2022 Q1
Q1 2020 $764,000 -$232,000 -23% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $996,000 -$294,000 -23% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $1,290,000 +$488,000 +61% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $802,000 +$118,000 +17% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $684,000 +$434,000 +174% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $250,000 +$188,339 +305% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $61,661 +$39,011 +172% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $22,650 -$51,703 -70% 01 Jan 2013 31 Mar 2013 10-Q 09 May 2014 2014 Q1
Q1 2012 $74,353 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013 2013 Q1

INTERCEPT PHARMACEUTICALS, INC. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $592,000 -$2,222,000 -79% 01 Jan 2022 31 Dec 2022 10-K 02 Mar 2023 2022 FY
2021 $2,814,000 -$129,000 -4.4% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023 2022 FY
2020 $2,943,000 -$720,000 -20% 01 Jan 2020 31 Dec 2020 10-K 02 Mar 2023 2022 FY
2019 $3,663,000 -$919,000 -20% 01 Jan 2019 31 Dec 2019 10-K 02 Mar 2022 2021 FY
2018 $4,582,000 -$19,000 -0.41% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $4,601,000 +$770,000 +20% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $3,831,000 +$2,140,000 +127% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $1,691,000 +$1,248,000 +282% 01 Jan 2015 31 Dec 2015 10-K 28 Feb 2018 2017 FY
2014 $443,000 +$337,000 +318% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $106,000 -$95,323 -47% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $201,323 -$209,278 -51% 01 Jan 2012 31 Dec 2012 10-K 02 Mar 2015 2014 FY
2011 $410,601 -$68,899 -14% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014 2013 FY
2010 $479,500 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.